Analyst Ratings for Silence Therapeutics (SLN)
SLN Rating Summary
SLN Price Target Summary
- Highest: $75.00 (H.C. Wainwright)
- Lowest: $15.00 (BTIG)
- Average: $50.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$50.50 (+125.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$50.50 (+125.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/31/2024 | BMO Capital » Updated 3/13/2024 |
Kostas Biliouris | New Coverage | Outperform (N/A) |
67.00 (N/A) |
18.90 (22.39) |
18.47% | Details |
| 5/8/2023 | Morgan Stanley » Updated 3/14/2024 |
Michael Ulz | New Coverage | Overweight (N/A) |
45.00 (29.00) |
6.18 (22.39) |
262.3% | Details |
 |
||||||||
|
||||||||
